After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Sarepta Therapeutics Inc is $1.99B. A total of 11.04 million shares were traded on the day, compared to an average of 11.42M shares.
In the most recent transaction, Sarepta Therapeutics, Inc. bought 9,265,312 shares of SRPT for 19.99 per share on Aug 13 ’25. In a previous transaction on Mar 12 ’25, Nicaise Claude sold 2,491 shares at 99.64 per share. SRPT shares that Director owns now total 27,812.
Among the insiders who bought shares, Nicaise Claude acquired of 2,491 shares on Mar 12 ’25 at a per-share price of $99.65. In another insider transaction, Wigzell Hans Lennart Rudolf sold 10,500 shares at $124.84 per share on Dec 12 ’24. Company shares held by the Director now total 22,840.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, SRPT has a high of $144.22 and a low of $10.41.
As of this writing, SRPT has an earnings estimate of -$0.15 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $1.4 per share and a lower estimate of -$1.53. The company reported an EPS of $0.62 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. SRPT’s latest balance sheet shows that the firm has $2.12B in Cash & Short Term Investments as of fiscal 2021. There were $1.15B in debt and $452.73M in liabilities at the time. Its Book Value Per Share was $13.89, while its Total Shareholder’s Equity was $928.01M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SRPT is Buy with a score of 3.04.
